165 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 4 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

F9Coagulation factor IXCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FCGR2AFc fragment of IgG, low affinity IIa, receptor (CD32)CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
FCGR2BFc fragment of IgG, low affinity IIb, receptor (CD32)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
FCGR3AFc fragment of IgG, low affinity IIIa, receptor (CD16a)CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
FGAFibrinogen alpha chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FGFR1Fibroblast growth factor receptor 1Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FN1Fibronectin 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
FSHRFollicle stimulating hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
Group enriched
GABBR1Gamma-aminobutyric acid (GABA) B receptor, 1FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
GABRA1Gamma-aminobutyric acid (GABA) A receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
GABRA2Gamma-aminobutyric acid (GABA) A receptor, alpha 2FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GABRA4Gamma-aminobutyric acid (GABA) A receptor, alpha 4FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Group enriched
GABRA5Gamma-aminobutyric acid (GABA) A receptor, alpha 5FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
GABRB1Gamma-aminobutyric acid (GABA) A receptor, beta 1FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Group enriched
GABRB3Gamma-aminobutyric acid (GABA) A receptor, beta 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
GABREGamma-aminobutyric acid (GABA) A receptor, epsilonFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
GABRG2Gamma-aminobutyric acid (GABA) A receptor, gamma 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
GABRG3Gamma-aminobutyric acid (GABA) A receptor, gamma 3FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
GABRPGamma-aminobutyric acid (GABA) A receptor, piFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
GABRR1Gamma-aminobutyric acid (GABA) A receptor, rho 1FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
GANABGlucosidase, alpha; neutral ABEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
GCGRGlucagon receptorFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
GHRGrowth hormone receptorDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Group enriched
GHRHRGrowth hormone releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GLRBGlycine receptor, betaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GRM5Glutamate receptor, metabotropic 5FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
HTR3A5-hydroxytryptamine (serotonin) receptor 3A, ionotropicFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Group enriched
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IDEInsulin-degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
IFNAR1Interferon (alpha, beta and omega) receptor 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IFNGInterferon, gammaCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IFNGR1Interferon gamma receptor 1CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IFNGR2Interferon gamma receptor 2 (interferon gamma transducer 1)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL11RAInterleukin 11 receptor, alphaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL1R1Interleukin 1 receptor, type ICancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL2RBInterleukin 2 receptor, betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL3RAInterleukin 3 receptor, alpha (low affinity)CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL6RInterleukin 6 receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ITGA4Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ITGB1Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
KCNN4Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
LIPFLipase, gastricEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
LPLLipoprotein lipaseCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
M6PRMannose-6-phosphate receptor (cation dependent)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
METMet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed

« prev | Page of 4 | next »